Resources

PATH has been contributing to Myanmar’s healthcare transformation since 2012 and supports the government’s commitment to achieve universal health coverage by 2030. PATH works with government, non-governmental actors, and private sector to leverage partnerships, policy advocacy, new technologies, and innovative approaches to address inequities in key health areas – nutrition, vaccines and immunization, sexual and reproductive health, infectious diseases, and non-communicable diseases.This factsheet talks about the various completed and ongoing projects under family health.

In 2021, PATH undertook a subnational assessment in Burkina Faso, Ethiopia, India, Kenya, and Nigeria on barriers and enablers to uptake and implementation of essential maternal, newborn, and child health and nutrition medicines, devices, and interventions—what we call “assets.” We conducted facility spot-checks of asset availability and interviewed healthcare providers and district health management teams on challenges and successes in the journey to scale for each of the 14 assets. The Insights Briefs summarize the findings for each focus country.

The purpose of this action brief is to review and discuss the current situation of Hepatitis-C Virus (HCV) among People Who Inject Drugs (PWID) in India. Further, this action brief would provide potential strategies in strengthening HCV screening, confirmatory testing, treatment initiation, and treatment completion among PWIDs in India.

Diagnostics are fundamental to accurate detection of disease and critical to informing effective clinical care and selection of treatment. Yet access to diagnostic testing has remained poor and inequitable in many parts of the world. Approximately 47 percent of the global population has little to no access to diagnostics. This challenge is particularly evident in low- and middle-income countries, where only 19 percent of patients have access to appropriate diagnostics at the primary health care level.To develop this report, PATH collaborated with Accenture to investigate access challenges within the diagnostics ecosystems in Latin America, Africa, and Southeast Asia to identify market failures and market-shaping interventions needed for LMICs and close the existing diagnostics gap. The report highlights existing market failures across the diagnostics value chain and provides recommendations for expanded access to quality diagnostics in low- and middle-income countries.Click here to view an interactive dashboard of diagnostic companies with a manufacturing presence based in Africa, Latin America, and Southeast Asia.

While Uganda has made significant progress in increasing access to immunization in recent years, vaccine inequity remains a challenge. The COVID-19 pandemic has further disrupted immunization efforts and disproportionately affected women and children in communities where vaccine coverage was already low. Disruption of immunization services, even for brief periods, can raise the likelihood of outbreaks of vaccine preventable diseases such as measles and polio, which can lead to increased morbidity and mortality and a greater burden on health systems already constrained by the pandemic.